Aspirin Use
Find information on Aspirin Use (ASA Use, Acetylsalicylic Acid Use) diagnosis, including clinical documentation, medical coding, and healthcare guidance. Learn about Aspirin use for preventative care, pain management, and other medical indications. This resource supports accurate medical coding and complete clinical documentation for Aspirin therapy. Explore Aspirin Use implications for patient care and medical record keeping.
Regular ingestion of aspirin, a common over-the-counter pain reliever and anti-inflammatory drug.
Usually asymptomatic. Overdose can cause tinnitus, nausea, vomiting, and abdominal pain.
Self-medication for pain, fever, or inflammation. Prescribed for heart attack and stroke prevention.
ICD-10 Code Families
Complete code families applicable to Z79.82
When to use each related code
| Description | When to use |
|---|---|
| Regular aspirin intake for prevention or treatment. | Document ongoing aspirin use, including low-dose for cardiac protection or higher doses for pain relief. |
| Adverse effects from aspirin, such as GI bleeding or tinnitus. | Code when aspirin use causes complications. Specify the adverse effect. |
| Stopping aspirin therapy due to side effects or other reasons. | Code when aspirin is discontinued due to adverse events, ineffectiveness, or other clinical considerations. |
Best-practice checklist
- ✓Document indication for aspirin use (e.g., primary prevention, secondary prevention, pain)
- ✓Specify aspirin dosage, frequency, and route of administration
- ✓Note duration of aspirin therapy or last dose taken
- ✓Document any aspirin-related adverse events (e.g., bleeding, GI upset)
- ✓Record patient education on aspirin risks and benefits
Common pitfalls to avoid
Coding Aspirin Use without specifying prophylactic, therapeutic, or other intent can lead to inaccurate risk adjustment and reimbursement.
Failing to document a patient's Aspirin allergy alongside Aspirin Use poses a significant patient safety risk and potential liability.
Coding Aspirin Use based solely on patient-reported history without provider confirmation can lead to coding errors and compliance issues.
Best-practice tips
- 01Document aspirin indication, dose, frequency, and route.
- 02Reconcile home meds: Query undocumented aspirin.
- 03Evaluate GI bleed risk. Code appropriately.
- 04Check for drug interactions. Document contraindications.
- 05Educate patients on risks and benefits of aspirin.
Step-by-step checklist
- 1
Verify aspirin use: dosage, frequency, indication (ICD-10-CM)
- 2
Document aspirin allergy status (SNOMED CT)
- 3
Check for drug interactions: NSAIDs, anticoagulants
- 4
Assess GI bleed risk factors: age, history, medications
- 5
Patient education: risks, benefits, bleeding signs
Ready-to-paste narrative
Patient reports regular aspirin use. History includes [frequency] intake of [dosage] mg aspirin for [indication, e.g., primary prevention of cardiovascular events, secondary prevention of stroke, pain management]. Assessed patient understanding of aspirin therapy including benefits, risks such as gastrointestinal bleeding and platelet dysfunction, and potential drug interactions. Counseled patient on signs and symptoms of aspirin overdose including tinnitus, hyperventilation, and metabolic acidosis. Discussed alternative pain management strategies if applicable. Documented aspirin use in medication reconciliation. ICD-10-CM code Z79.891 (long term current drug therapy) and medication code for aspirin were considered for billing and coding purposes. Plan includes continued monitoring for efficacy and adverse effects of aspirin therapy. Patient education provided regarding the importance of informing all healthcare providers of aspirin use prior to any procedures or surgeries.
Common questions and answers
What are the evidence-based recommendations for low-dose aspirin use in primary prevention of cardiovascular disease in asymptomatic adult patients?+
Current guidelines from the US Preventive Services Task Force (USPSTF) recommend against initiating low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) in adults 60 years or older. For adults aged 40-59 years, the decision to initiate low-dose aspirin use should be individualized based on a shared decision-making process between the clinician and patient, considering factors such as estimated 10-year CVD risk, potential benefits, and bleeding risks. The USPSTF recommends against initiating low-dose aspirin for primary prevention in adults of any age with a high risk of bleeding. It's important to note that these recommendations apply to asymptomatic adults without pre-existing CVD. Explore how shared decision-making tools can facilitate discussions about aspirin use with your patients.
How do I manage aspirin therapy in patients undergoing surgical procedures, considering the risk of perioperative bleeding complications?+
The management of aspirin therapy in patients undergoing surgical procedures requires careful consideration of the balance between bleeding risk and thrombotic risk. For patients on low-dose aspirin for primary CVD prevention, current guidelines suggest discontinuation 7 days prior to elective procedures with moderate to high bleeding risk. However, for patients on aspirin for secondary prevention (e.g., after myocardial infarction or stroke), the benefits of continued aspirin therapy generally outweigh the bleeding risks, and discontinuation is typically not recommended. In such cases, strategies to minimize bleeding risk, such as careful surgical technique and use of local hemostatic measures, should be considered. Consult the latest surgical guidelines specific to the procedure for detailed recommendations. Consider implementing a standardized perioperative medication management protocol in your practice to optimize patient safety.
What are the potential drug interactions between aspirin and other commonly prescribed medications, such as anticoagulants and NSAIDs, and how should they be managed clinically?+
Aspirin can interact with several medications, increasing the risk of adverse events. Combining aspirin with anticoagulants like warfarin or direct oral anticoagulants (DOACs) substantially increases the risk of bleeding. Co-administration requires careful monitoring of coagulation parameters and dosage adjustments as needed. Concurrent use of aspirin with nonsteroidal anti-inflammatory drugs (NSAIDs) can also increase bleeding risk and may reduce the cardioprotective effects of aspirin. If concurrent NSAID use is necessary, consider using alternative analgesics like acetaminophen or COX-2 inhibitors (celecoxib) with close monitoring. Learn more about managing polypharmacy and minimizing drug interactions in your patients receiving aspirin therapy.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.